IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis

Vaccine

Volumn 21, Issue 19-20, 2003, Pages 2589-2597

  De Oliveira Mendes, Carolina ^a   Paraguai De Souza, Edilma ^a   Borja Cabrera, Gulnara Patrícia ^a   Melo Batista, Leopoldina Maria ^b   Aparecida Dos Santos, Miriam ^c   Parra, Luciana Ellner ^c   Menz, Ingrid ^c   Palatnik, Marcos ^a   Palatnik De Sousa, Clarisa Beatriz ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b CENTRO DE CONTROLE DE ZOONOSES   (Brazil)

^c ZOETIS   (United States)

Author keywords

Canine visceral leishmaniosis; Fucose mannose ligand; IgG1; IgG2; Leishmania chagasi; Leishmania donovani; Saponins; Vaccine; Zoonoses

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; LEISHMANIA DONOVANI VACCINE; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOG; HUMORAL IMMUNITY; LEISHMANIA DONOVANI; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VISCERAL LEISHMANIASIS;

EID: 0038740849     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00046-X     Document Type: Article

References (38)

1. Tesh R. Control of zoonotic visceral leishmaniasis: Is it time to change strategies? Am. J. Trop. Med. Hyg. 52:1995;287-292.
2. Dye C. The logic of visceral leishmaniasis control. Am. J. Trop. Med. Hyg. 55:1996;125-130.
3. Palatnik-de-Sousa C.B., Santos W.R., França-Silva J.C., da Costa R.T., Barbosa Reis A., Palatnik M.et al. Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil. Am. J. Trop. Med. Hyg. 65:2001;510-517.
4. Palatnik de Sousa C.B., Paraguai de Souza E., Gomes E.M., Borojevic R. Experimental murine Leishmania donovani infection: immunoprotection by the fucose-mannose ligand (FML). Braz. J. Med. Biol. Res. 27:1994;547-551.
5. Santos W.R., Paraguai de Souza E., Palatnik M., Palatnik de Sousa C.B. Vaccination with the FML antigen (fucose-mannose ligand) of Leishmania donovani in the Swiss Albino model. Vaccine. 17:1999;2554-2561.
6. Santos W.R., de Lima V.M.F., Paraguai de Souza E., Bernardo R.R., Palatnik M., Palatnik de Sousa C.B. Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis. Vaccine. 21:2002;30-43.
7. Palatnik de Sousa C.B., Moreno M.B., Paraguai de Souza E., Borojevic R. The fucose-mannose ligand (FML) vaccine protects hamsters from experimental kala-azar. Ciência e Cultura (J. Braz. Assoc. Adv. Sci.). 46:1994;290-296.
8. da Silva V.O., Borja-Cabrera G.P., Correia Pontes N.N., Paraguai de Souza E., Luz K.G., Palatnik M.et al. A Phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (São Gonçalo do Amarante, RN). Vaccine. 19:2001;1068-1081.
9. Borja-Cabrera G.P., Correia Pontes N.N., da Silva V.O., Paraguai de Souza E., Santos W.R., Gomes E.M.et al. Long-lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (São Gonçalo do Amarante). Vaccine. 20:2002;3277-3284.
10. Borja Cabrera G.P., da Silva V.O., da Costa R.T., Barbosa Reis A., Mayrink W., Genaro O.et al. The FML-ELISA assay in diagnosis and prognosis of canine visceral leishmaniasis. Am. J. Trop. Med. Hyg. 61:1999;296-301.
11. Elassad A.M.S., Younis S.A., Siddig M., Garyson J., Petersen E., Ghalib H.W. The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients. Clin. Exp. Immunol. 95:1994;294-299.
12. Chatterjee M., Basu K., Basu D., Bannerjee D., Pramanil N., Guha S.K.et al. Distribution of IgG subclasses in antimonial unresponsive Indian kala-azar patients. Clin. Exp. Immunol. 114:1998;408-413.
13. Marciani D.J., Pathak A.K., Reynolds R.C., Seitz L., May R.D. Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponins. Int. Immunopharmacol. 1:2001;813-818.
14. Deplazes P., Smith N.C., Arnold P., Lutz H., Eckert J. Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites. Parasite Immunol. 17:1995;451-458.
15. Palatnik C.B., Borojevic R., Previato J.O., Mendonça-Previato L. Inhibition of Leishmania donovani promastigote internalization into murine macrophages by chemically defined parasite glycoconjugate. Infect. Immun. 57:1989;754-763.
16. Palatnik de Sousa C.B., Gomes E.M., Paraguai de Souza E., Luz K., Palatnik M., Borojevic R. Leishmania donovani: titration of antibodies to the fucose-mannose ligand as an aid in diagnosis and prognosis of visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 89:1995;390-393.
17. Paranhos-Silva M., Freitas L.A., Santos W.C., Grimaldi G. Jr., Pontes de Carvalho L., Oliveira dos Santos A. A cross-sectional serodiagnostic survey of canine leishmaniasis due to Leishmania chagasi. Am. J. Trop. Med. Hyg. 55:1996;39-44.
18. Ashford D.A., Badaró R., Eulalio C., Freire M., Miranda C., Zalis M.et al. Studies on the control of visceral leishmaniasis: validation of the Falcon assay screening test-enzyme linked immunosorbent assay (Fast-ELISA™) for field diagnosis of canine visceral leishmaniasis. Am. J. Trop. Med. Hyg. 48:1993;1-8.
19. Dietze R., Baptista Barros G., Teixeira L., Harris J., Michelson K., Falqueto A.et al. Effect of eliminating seropositive canines on the transmission of visceral leishmaniasis in Brazil. Clin. Infect. Dis. 25:1997;1240-1242.
20. Cabral M., O'Gradi J.E., Alexander J. Demostration of Leishmania specific cell mediated and humoral immunity in asymptomatic dogs. Parasite Immunol. 14:1992;531-539.
21. Pinelli E., Killick-Kendrick R., Wagennar E., Barnadina W., del Real G., Ruitenberg J. Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania (L.) infantum. Infect. Immun. 62:1994;229-235.
22. Solano-Gallego L., Riera C., Roura X., Inieste L., Gallego M., Valladares J.E.et al. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas: evolution in the course of infection and after treatment. Vet. Parasitol. 96:2001;265-276.
23. Borja Cabrera GP. Análise do potencial diagnóstico, prognóstico e imunoprotetor do antígeno FML (Ligante de Fucose Manose) de Leishmania (L.) donovani, no calazar canino experimental e de área endêmica. Ph.D. Thesis. Post-Graduate Program in Experimental Pahotology. Niteroi, Rio de Janeiro, Brazil: Federal Fluminense University; 2000.
24. Paraguai de Souza E., Borja Cabrera G.P., Pereira T.R.D., da Silva V.O., Correia-Pontes N.N., Freire T.C.et al. Occurrence of Leishmania donovani DNA in bone marrow of FML-seroreactive Brazilian blood donors. Transfusion. 39(10S):1999;117S.
25. Travi B.L., Tabares C.J., Cadena H., Ferro C., Osorio Y. Canine visceral leishmaniasis in Colombia: relationship between clinical and parasitologic status and infectivity for sand flies. Am. J. Trop. Med. Hyg. 64:2001;119-124.
26. Carvalho E.M., Bacellar O., Barral A., Badaro R., Reed S.G., Johnson W.D. Antigen-specific immunosupression in visceral leishmaniasis is cell mediated. J. Clin. Invest. 83:1989;860-864.
27. Solano-Gallego L, Llul J, Ramos G, Riera C, Arboix M, Alberola J, Ferrer L. The Ibizian hound presents a predominanttly cellular immune response against natural Leishmania infection. Vet. Parasitol. 2000;37-45.
28. Basak S.K., Saha B., Bhattacharya A., Roy S. Immunobiological studies on experimental visceral leishmaniasis. II. Adherent cell-mediated down-regulation of delayed-type hypersensitivity response and up-regulation of B cell activation. Eur. J. Immunol. 22:1992;2041-2045.
29. Guarga J.L., Moreno J., Lucientes J., Gracia M.J., Peribanez M.A., Alvar J.et al. Canine leishmaniasis transmission: higher infectivity among naturally infected dogs to sandflies is associated with lower proportions of T helper cells. Res. Vet. Sci. 69:2000;249-253.
30. Bourdoiseau G., Bonnefont C., Hoareau E., Boehringer C., Stolle T., Chabanne L. Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs. Vet. Immunopathol. 59:1997;21-30.
31. Moreno J., Nieto J., Chamizo C., Gonzalez F., Blanco F., Barker F.et al. The immune response and PBMC subsets in canine visceral leishmaniasis before and after chemotherapy. Vet. Immunopathol. 30:1999;181-195.
32. Cruz Mendes A, Borja Cabrera GP, Paraguai de Souza E, Santos WR, Gomes EM, Palatnik de Sousa CB. Immunotherapy against canine kala-azar with the FML antigen of L. (L.) donovani and the QuilA saponin. In: Proceedings of the V Meeting on Applied Research on Leishmaniasis. Uberaba, MG, Brazil. p. 80-1.
33. Nieto C.G., Garcia Alonso M., Requena J.M., Miron C., Soto M., Alonso C.et al. Analysis of the humoral response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis. Vet. Immunol. Immunopathol. 67:1999;117-130.
34. Santana D.M., Paraguai de Souza E., Borja-Cabrera G.P., Sturm N.R., Palatnik de Sousa C.B., Campbell D.A. Nucleoside hydrolase from Leishmania (L.) donovani is an antigen diagnostic for visceral leishmaniasis. Mol. Biochem. Parasitol. 120:2002;315-319.
35. Paraguai de Souza E., Bernardo R.R., Palatnik M., Palatnik de Sousa C.B. Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani. Vaccine. 19/23-24:2001;3104-3115.
36. Palatnik de Sousa C.B., Gomes E.M., Paraguai de Souza E., Santos W.R., Macedo S.R., Medeiros L.V.et al. The fucose-mannose ligand (FML) of Leishmania donovani: a new tool in diagnosis, prognosis, transfusional control and vaccination against human Kala-azar. Rev. Soc. Bras. Med. Trop. 29:1996;153-163.
37. Ma J., Bulger P.A., Dante S., Davis Dv.R., Perilli-Palmer B., Coughlin R.T. Characterization of canine humoral immune responses to outer surface protein subunit vaccines and to natural infection by Lyme disease spirochetes. J. Infect. Dis. 171:1995;909-915.
38. Chabalgoity J.A., Moreno M., Carol H., Dougan G., Hormaeche C.E. Salmonella typhimurium as a basis for a live oral Echinococcus granulosus vaccine. Vaccine. 19:2001;460-469.